Dr. Alexander Breidenbach, MBA
Chief Business Officer
Nationality: German
Date of initial appointment: September 1, 2023
Dr. Breidenbach was appointed Chief Business Officer (CBO) in September 2023.
Dr. Breidenbach has more than 20 years of partnering, R&D and management experience in bioscience. Dr. Breidenbach is responsible for the development and execution of our growth strategy and our future plans.
Prior to joining Pharming, Dr. Breidenbach held several senior positions including Chief Business and Chief Development Officer at ACM Biosciences AG, as well as a variety of senior leadership roles at Roche Partnering. Dr. Breidenbach holds a PhD in Biochemistry from the Tierärztliche Hochschule (College of Veterinary Medicine) Hannover, Germany, as well as a Master of Business Administration from ESSEC Paris and Mannheim Business School.
ABOUT US | EXECUTIVE COMMITTEE | BOARD OF DIRECTORS | CORPORATE GOVERNANCE